JP2012508027A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012508027A5 JP2012508027A5 JP2011535765A JP2011535765A JP2012508027A5 JP 2012508027 A5 JP2012508027 A5 JP 2012508027A5 JP 2011535765 A JP2011535765 A JP 2011535765A JP 2011535765 A JP2011535765 A JP 2011535765A JP 2012508027 A5 JP2012508027 A5 JP 2012508027A5
- Authority
- JP
- Japan
- Prior art keywords
- cadherin
- seq
- diabody
- cells
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11304208P | 2008-11-10 | 2008-11-10 | |
| US61/113,042 | 2008-11-10 | ||
| PCT/US2009/063881 WO2010054377A2 (en) | 2008-11-10 | 2009-11-10 | Fully human antibodies against n-cadherin |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2012508027A JP2012508027A (ja) | 2012-04-05 |
| JP2012508027A5 true JP2012508027A5 (enExample) | 2012-12-20 |
Family
ID=42153647
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011535765A Pending JP2012508027A (ja) | 2008-11-10 | 2009-11-10 | Ｎ−カドヘリンに対する完全ヒト抗体 |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US8703920B2 (enExample) |
| EP (1) | EP2356145A4 (enExample) |
| JP (1) | JP2012508027A (enExample) |
| KR (1) | KR20110084309A (enExample) |
| CN (1) | CN102300873A (enExample) |
| AU (1) | AU2009313239A1 (enExample) |
| BR (1) | BRPI0921457A2 (enExample) |
| CA (1) | CA2743122A1 (enExample) |
| CO (1) | CO6362022A2 (enExample) |
| IL (1) | IL212795A0 (enExample) |
| MX (1) | MX2011004945A (enExample) |
| RU (1) | RU2011123655A (enExample) |
| WO (1) | WO2010054377A2 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8663635B2 (en) * | 2006-03-21 | 2014-03-04 | The Regents Of The University Of California | N-cadherin: target for cancer diagnosis and therapy |
| AU2007227195A1 (en) * | 2006-03-21 | 2007-09-27 | The Regents Of The University Of California | N-cadherin and Ly6 E: targets for cancer diagnosis and therapy |
| KR20100132998A (ko) * | 2008-04-04 | 2010-12-20 | 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 | 종양 성장, 혈관신생 및 전이를 차단하는 것을 목표로 하는 암에 대한 항체 |
| US8703920B2 (en) | 2008-11-10 | 2014-04-22 | The Regents Of The University Of California | Fully human antibodies against N-cadherin |
| GB201119089D0 (en) | 2011-11-04 | 2011-12-21 | Isis Innovation | Treatment of musculoskeletal fibroproliferative disorders |
| US20150050240A1 (en) | 2012-03-27 | 2015-02-19 | Novartis Ag | Treatment of fibrosis |
| CN107076160B (zh) * | 2014-08-21 | 2019-12-20 | 江森自控科技公司 | 电池监测系统 |
| WO2018226795A1 (en) * | 2017-06-06 | 2018-12-13 | The Regents Of The University Of California | Humanized anti-n-cadherin antibodies and uses thereof |
| KR20240007939A (ko) * | 2021-05-13 | 2024-01-17 | 우시 바이올로직스 아일랜드 리미티드 | 항-p-카드헤린 항체를 포함하는 항체 콘쥬게이트 및 이의 용도 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5889157A (en) * | 1990-10-12 | 1999-03-30 | The United States Of America As Represented By The Department Of Health And Human Services | Humanized B3 antibody fragments, fusion proteins, and uses thereof |
| CA2078539C (en) * | 1991-09-18 | 2005-08-02 | Kenya Shitara | Process for producing humanized chimera antibody |
| US6680175B2 (en) * | 1998-05-05 | 2004-01-20 | Adherex Technologies, Inc. | Methods for diagnosing and evaluating cancer |
| US6277824B1 (en) * | 1998-07-10 | 2001-08-21 | Adherex Technologies | Compounds and methods for modulating adhesion molecule function |
| AU2001249064A1 (en) | 2000-02-22 | 2001-09-03 | Mount Sinai School Of Medicine Of New York University | N-cadherin modulated migration, invasion, and metastasis |
| US20030190602A1 (en) * | 2001-03-12 | 2003-10-09 | Monogen, Inc. | Cell-based detection and differentiation of disease states |
| DK1629011T3 (da) * | 2003-05-31 | 2010-05-03 | Micromet Ag | Humane anti-humane-DC3-bindingsmolekyler |
| EP1786463A4 (en) * | 2004-03-26 | 2009-05-20 | Human Genome Sciences Inc | ANTIBODY AGAINST NOGO RECEPTOR |
| US20070105133A1 (en) * | 2005-06-13 | 2007-05-10 | The Regents Of The University Of Michigan | Compositions and methods for treating and diagnosing cancer |
| US20100278821A1 (en) * | 2006-03-21 | 2010-11-04 | The Regents Of The University Of California | N-cadherin: target for cancer diagnosis and therapy |
| AU2007227195A1 (en) | 2006-03-21 | 2007-09-27 | The Regents Of The University Of California | N-cadherin and Ly6 E: targets for cancer diagnosis and therapy |
| US8663635B2 (en) * | 2006-03-21 | 2014-03-04 | The Regents Of The University Of California | N-cadherin: target for cancer diagnosis and therapy |
| KR20100132998A (ko) * | 2008-04-04 | 2010-12-20 | 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 | 종양 성장, 혈관신생 및 전이를 차단하는 것을 목표로 하는 암에 대한 항체 |
| US8703920B2 (en) | 2008-11-10 | 2014-04-22 | The Regents Of The University Of California | Fully human antibodies against N-cadherin |
-
2009
- 2009-11-09 US US12/590,601 patent/US8703920B2/en not_active Expired - Fee Related
- 2009-11-10 WO PCT/US2009/063881 patent/WO2010054377A2/en not_active Ceased
- 2009-11-10 JP JP2011535765A patent/JP2012508027A/ja active Pending
- 2009-11-10 CA CA2743122A patent/CA2743122A1/en not_active Abandoned
- 2009-11-10 AU AU2009313239A patent/AU2009313239A1/en not_active Abandoned
- 2009-11-10 MX MX2011004945A patent/MX2011004945A/es unknown
- 2009-11-10 EP EP09825592A patent/EP2356145A4/en not_active Withdrawn
- 2009-11-10 RU RU2011123655/10A patent/RU2011123655A/ru unknown
- 2009-11-10 KR KR1020117013339A patent/KR20110084309A/ko not_active Withdrawn
- 2009-11-10 CN CN2009801544698A patent/CN102300873A/zh active Pending
- 2009-11-10 BR BRPI0921457A patent/BRPI0921457A2/pt not_active Application Discontinuation
-
2011
- 2011-05-09 IL IL212795A patent/IL212795A0/en unknown
- 2011-06-08 CO CO11070983A patent/CO6362022A2/es not_active Application Discontinuation
-
2013
- 2013-06-17 US US13/919,652 patent/US20140017240A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN110536900B (zh) | 调节补体依赖性细胞溶解效应子功能的修饰的人igm恒定区 | |
| CN105837688B (zh) | 单域抗体及其编码基因，免疫毒素及其编码基因、制备方法、表达载体、应用，及宿主细胞 | |
| CN109206514B (zh) | Tslp单克隆抗体及其制备方法和应用 | |
| JP2018503401A (ja) | 腫瘍壊死因子 （ｔｎｆ） スーパーファミリー受容体結合分子およびその使用 | |
| CN106117354B (zh) | 一种全人源抗CD47的全分子IgG抗体及其应用 | |
| CN113480657B (zh) | 针对her2的单域抗体及其衍生蛋白和应用 | |
| RU2009118621A (ru) | Агонистические антитела против notch3 и их применение для лечения ntch3-ассоциированных заболеваний | |
| JP2003510366A (ja) | Ａｐｒｉｌレセプター（ｂｃｍａ）およびその使用 | |
| KR101671955B1 (ko) | 항 ＴＮＦ-α/ＣＸＣＬ10 이중 타겟 항체 및 그의 용도 | |
| CN111620951B (zh) | EGFP-Wnt2融合蛋白抗原和Wnt2单克隆抗体以及Wnt2单克隆抗体的应用 | |
| CN105384818A (zh) | 抗人Delta like 4单克隆抗体及其应用 | |
| CN109705225B (zh) | 一种抗人caix抗原的嵌合抗原受体及其应用 | |
| CN101293924A (zh) | 骨桥蛋白的功能表位、与其特异性结合的单克隆抗体及其在制备抗肿瘤转移药物中的用途 | |
| CN113321721B (zh) | 一种细胞外Ezrin蛋白及其应用 | |
| CN115058430B (zh) | 一种拟穴青蟹5-ht2受体基因及其应用 | |
| WO2011024114A1 (en) | Targeting extracellular matrix molecules for the treatment of cancer | |
| CN101143902A (zh) | 抗HER2单链抗体-力达霉素强化融合蛋白HER2(Fv-LDM) | |
| US20230065153A1 (en) | Anti-integrin alpha-11 monoclonal antibody and use thereof | |
| KR101473328B1 (ko) | 사이토케라틴１７―특이적인 인간항체 | |
| CN117866903B (zh) | 单域抗体修饰的干细胞及其在疾病治疗中用途 | |
| JP6574033B2 (ja) | Ｗｎｔ蛋白質の製造方法および保存方法 | |
| CN101544695A (zh) | 人源化抗cd25单链抗体及制备方法 | |
| CN117866902A (zh) | 具有抗il-17a活性的基因修饰干细胞及其制备方法以及药物组合物 | |
| CN110117325B (zh) | 一种猪cd127多肽及其编码基因和应用 | |
| JP3288716B2 (ja) | ヒト接着分子オクルディン |